About this trial
In this project, we aim to validate a Home Hospitalization plan for patients with TIA or minor stroke. Our hypothesis is that our Multimodal Home Hospitalization program (NORAHOME) for patients with TIA and minor stroke is safe, reduces the complications associated with conventional hospitalization, and is more efficient than Standard Clinical Practice. To conduct the study, we require the voluntary participation of patients with TIA and minor strokes.
Eligibility criteria
Qualifiers
Age >18 years.
Availability of a smartphone for the patient or caregiver.
Family support and/or formal caregiver.
Clinical stability during the last 12 hours in the Emergency Department.
Disqualifiers
Severe stenosis or symptomatic arterial occlusion requiring admission for potential reperfusion and/or arterial revascularization treatments.
Patients with pre-existing neurological or psychiatric conditions that may interfere with or complicate follow-up and evaluations.
Clinical (terminal condition) or social (language barrier) impossibility to complete follow-up assessments.
Trial design
Treatments tested in this trial
- Home hospitalization
Treatment groups
Sponsors and collaborators
Hospital Universitari Vall d'Hebron Research Institute
Lead sponsor
Vall Hebron Insitut Recerca
Collaborator
Hospital Vall d'Hebron
Collaborator